- Release Date: 18/12/23 09:02
- Summary: P2 trial shows significant improvements in Phelan-McDermid
- Price Sensitive: Yes
- Download Document 723.12KB
Ann: P2 trial shows significant improvements in Phelan-McDermid
-
- There are more pages in this discussion • 210 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$19.85 |
Change
-0.060(0.30%) |
Mkt cap ! $2.535B | |||
| Open | High | Low | Value | Volume |
| $19.88 | $19.99 | $19.73 | $502.8K | 25.33K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 166 | $19.83 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $19.85 | 61 | 4 |
View Market Depth
| Last trade - 10.48am 21/06/2024 (20 minute delay) ? |
| NEU (ASX) Chart |